Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Revenues $ 0 $ 390
Operating expenses:    
Research and development (related party of $153 and $95 for the three months ended September 30, 2013 and 2012, respectively) 552 1,177
Research and development - effect of Settlement Agreement (Note 6) (1,041) 0
General and administrative 949 1,023
General and administrative - effect of Settlement Agreement (Note 6) (700) 0
Total operating expenses (240) 2,200
Operating income (loss) 240 (1,810)
Other income (expense):    
Interest income 2 4
Interest expense 0 (15)
Interest expense - effect of Settlement Agreement (Note 6) 122 0
Royalty income 15 11
Change in fair value of warrant derivative liability 0 (241)
Net income (loss) $ 379 $ (2,051)
Earnings (loss) per common share - basic (in dollars per share) $ 0.01 $ (0.04)
Earnings (loss) per common share - diluted (in dollars per share) $ 0.01 $ (0.04)
Weighted-average common shares outstanding - basic (in shares) 56,692 47,767
Weighted-average common shares outstanding - diluted (in shares) 60,626 47,767